Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07090005 · ClinicalTrials.gov registry record · NA
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
A NA study of Obesity and Overweight, sponsored by Nitinotes Surgical.
- Recruiting
- Registry status
- NA
- Development phase
- 184
- Enrollment target
- 2
- Study locations
NCT07090005: Recruiting NA study of Obesity and Overweight, sponsored by Nitinotes Surgical.
NCT07090005 is a NA study of Obesity and Overweight that is actively recruiting participants, run by Nitinotes Surgical. The registered enrollment target is 184 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07090005, a NA study of Obesity and Overweight, is actively recruiting participants, sponsored by Nitinotes Surgical.
- RECRUITING
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
- 2
- Study locations
Study Summary
evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
Conditions Studied
Interventions
- DEVICE EndoZip System
- DEVICE OverStitch Endoscopic Suturing System (ESG)
Study Locations (2)
California
- Cedars Sinai Medical Center - Los Angeles
New York
- Lenox Hill Hospital | Northwell Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2025-11-14 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
What NCT07090005 shows while recruiting
NCT07090005 is an interventional study that assigns participants to a tested intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which EndoZip System is the first listed.
NCT07090005 reports a single indexed study location in California, New York.
Frequently Asked Questions
What is clinical trial NCT07090005 about?
NCT07090005 is a clinical study titled "Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients". evaluation of the EndoZip system procedure compared to the Apollo ESG procedure in obese patients.
What is the current status of trial NCT07090005?
This trial is currently recruiting. It is a NA study. The enrollment target is 184 participants. The study started on 2025-11-14. Estimated completion is 2027-07-01.
What conditions does trial NCT07090005 study?
This clinical trial studies the following conditions: Obesity, Overweight.
What interventions are being tested in trial NCT07090005?
The interventions under investigation include: EndoZip System (DEVICE), OverStitch Endoscopic Suturing System (ESG) (DEVICE).
Who is sponsoring clinical trial NCT07090005?
This trial is sponsored by Nitinotes Surgical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07090005 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07090005's enrollment target sits among peer trials
184 336th of 1053 higher than 718 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03903510 · 184 participants · NA
Virtual Reality During Pediatric Cast Removal
- NCT04020510 · 184 participants · Phase 4
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
- NCT04135846 · 184 participants · Phase 2
Alpha-1 Blockade for Alcohol Use Disorder (AUD)
- NCT04396873 · 184 participants · Phase 1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI